ANDRÉS
CATENA MARTÍNEZ
CATEDRÁTICO DE UNIVERSIDAD
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (12)
2023
-
Active Gains in brain Using Exercise During Aging (AGUEDA): protocol for a randomized controlled trial
Frontiers in Human Neuroscience, Vol. 17
-
Early life factors and structural brain network in children with overweight/obesity: The ActiveBrains project
Pediatric Research
-
Neurotrophic factors and brain health in children with overweight and obesity: The role of cardiorespiratory fitness
European Journal of Sport Science, Vol. 23, Núm. 4, pp. 637-648
2022
-
Infant Formula Supplemented With Milk Fat Globule Membrane, Long-Chain Polyunsaturated Fatty Acids, and Synbiotics Is Associated With Neurocognitive Function and Brain Structure of Healthy Children Aged 6 Years: The COGNIS Study
Frontiers in Nutrition, Vol. 9
-
Influence of Gestational Diabetes and Pregestational Maternal BMI on the Brain of Six-Year-Old Offspring
Pediatric Neurology, Vol. 133, pp. 55-62
2021
-
Activity-rest circadian pattern and academic achievement, executive function, and intelligence in children with obesity
Scandinavian Journal of Medicine and Science in Sports, Vol. 31, Núm. 3, pp. 653-664
2020
-
Effects of Maternal Fish Oil and/or 5-Methyl-Tetrahydrofolate Supplementation during Pregnancy on Offspring Brain Resting-State at 10 Years Old: A Follow-Up Study from the NUHEAL Randomized Controlled Trial
Nutrients, Vol. 12, Núm. 9
-
Influence of a functional nutrients-enriched infant formula on language development in healthy children at four years old
Nutrients, Vol. 12, Núm. 2
-
The effects of an infant formula enriched with milk fat globule membrane, long-chain polyunsaturated fatty acids and synbiotics on child behavior up to 2.5 years old: The cognis study
Nutrients, Vol. 12, Núm. 12, pp. 1-16
-
The nutritional profile of food advertising for school-aged children via television: A longitudinal approach
Children, Vol. 7, Núm. 11
2019
2015
-
Maternal PPARG Pro12Ala polymorphism is associated with infant's neurodevelopmental outcomes at 18months of age
Early Human Development, Vol. 91, Núm. 8, pp. 457-462